1. El-Zayadi AR, Badran HM, Barakat EMF, Attia MED, Shawky S, Mohamed MK, Selim O, Saed A. Hepatocellular carcinoma in Egypt: a single center study over a decade. World J Gastroenterol. 2005;11:5193–8.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
3. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram IBF. Global Cancer observatory Cancer today. In: Lyon, France: International agency for research on cancer; 2018. https://gco.iarc.fr/today. Accessed 17 Aug 2020.
4. Omar A, Abou-Alfa GK, Khairy A, Omar H. Risk factors for developing hepatocellular carcinoma in Egypt. Chin Clin Oncol. 2013; https://doi.org/10.3978/j.issn.2304-3865.2013.11.07.
5. Kanda T, Jiang X, Yokosuka O. Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancers. World J Gastroenterol. 2014;20:9229–36.